Dr. Lal Path Labs Reports 15.5% Drop in Profit Despite 16.6% Revenue Increase in Q4 FY26
SKIP_POST
⚡⚡Latest:
- US Stocks Surge: S&P 500 and Nasdaq Climb Higher as Tech and Chipmakers Bounce Back.
- Current Account Surplus Achieved in Q4 FY26, Marking a Significant Economic Milestone!
- Government to offload 3% stake in NLC India at a floor price of Rs 303 through Offer for Sale (OFS).
- Apple Unveils iOS 27 Featuring Enhanced Liquid Glass Technology: Discover the Latest Features and Compatible Devices!
- Lilly Shares Surge on Optimism for Next-Gen Drug to Dominate Weight-Loss Market
Tuesday, June 9, 2026
Smart Market Insights